Collaborative project - Nanoparticles designed to target chemokine-related inflammatory processes in vascular diseases and cancer metastasis (NANODIATER) - Sub-project - Targeting of nanoparticles and in vitro simulation of chemokine inhibition to fight inflammation and metastatic spread. This project was identified by RTI International for their own research purposes and some fields do not align with The GO Map categories. End dates were estimated as one year after the start date. The Project Type "Research, Clinical" may not accurately describe this project's focus but was used for all RTI International's Global Noncommunicable Diseases Initiative projects added in June 2018. Specialties were not analyzed. All project funding was valued in 2015 USD.